Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03309878
Brief Title: Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

First Submitted : October 13, 2017
First Submitted that Met QC Criteria : October 13, 2017
First Posted : October 16, 2017

Last Update Submitted that Met QC Criteria : July 8, 2021
Last Update Posted : July 9, 2021